Paul N. Mudd, Jr.
12Patents
4h-index
12Co-inventors
49Inventor score
Filing activity: Jun 6, 2018 → Nov 5, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10449191B2 | Treatment of prostate cancer | Human Necessities | 11 | Active |
| US10786501B2 | Treatment of prostate cancer | Human Necessities | 10 | Active |
| US11583526B2 | Treatment of prostate cancer | Human Necessities | 8 | Active |
| US11033551B2 | Methods of treating uterine fibroids | Human Necessities | 4 | Active |
| US12097198B2 | Treatment of prostate cancer | Human Necessities | 3 | Active |
| US12144809B1 | Treatment of prostate cancer | Human Necessities | 2 | Active |
| US11957684B2 | Treatment of heavy menstrual bleeding associated with uterine fibroids | Human Necessities | 1 | Active |
| US12102638B2 | Use of vibegron to treat overactive bladder | Human Necessities | 1 | Active |
| US11793812B2 | Methods of treating endometriosis | Human Necessities | 1 | Active |
| US11918583B2 | Treatment of heavy menstrual bleeding associated with uterine fibroids | General | 0 | Revoked |
| US12357636B2 | Vibegron for the treatment of overactive bladder symptoms | Human Necessities | 0 | Active |
| US12336990B2 | Treatment of prostate cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.